Clinical Trial Update: Clinical Trial of Recombinant Hepatitis E Vaccine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a recombinant hepatitis E vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Drugs mentioned

• Recombinant Hepatitis E vaccine

Snippet

Sponsor: Xiamen University | Conditions: Hepatitis E | Phase 3 | Status: COMPLETED